Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

COMy 2025 | Organs or tissues frequently affected by extramedullary disease in patients with myeloma

In this video, Saurabh Zanwar, MD, MBBS, Mayo Clinic, Rochester, MN, briefly discusses which tissues are affected by extramedullary disease (EMD) in multiple myeloma. Dr Zanwar highlights that EMD can affect any organ system, and approximately 50% of patients experience visceral involvement. This interview took place at the 11th World Congress on Controversies in Multiple Myeloma (COMy) congress in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

Yeah, there is no peculiar distinction in terms of tissues that are involved by extramedullary disease. It can involve pretty much any organ system, including anything head to toe really. So central nervous system, liver, pancreas, soft tissue, lymph node. What we have noted in the past is about 50% of patients have a visceral involvement, whereas the rest of the half have soft tissue or skin involvement...

Yeah, there is no peculiar distinction in terms of tissues that are involved by extramedullary disease. It can involve pretty much any organ system, including anything head to toe really. So central nervous system, liver, pancreas, soft tissue, lymph node. What we have noted in the past is about 50% of patients have a visceral involvement, whereas the rest of the half have soft tissue or skin involvement. There is some data to suggest that visceral extramedullary disease might have a worse outcome compared to soft tissue or lymph node extramedullary sites, but there is more granularity in that data to dig through.

 

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...